The videogame retailer’s shares jumped following the latest cryptic post from influential trader Keith Gill, aka “Roaring ...
Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...
What makes that call particularly surprising is that most pundits are still skeptical about Palantir. Among the 20 analysts ...
Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...
Wedbush analyst Daniel Ives raised the firm’s price target on Salesforce (CRM) to $425 from $375 and keeps an Outperform rating on the shares. The firm notes the company delivered its Q3 results ...
https://www.tipranks.com/news/the-fly/snap-price-target-raised-to-13-from-11-at-citi As previously reported, Wedbush upgraded Pinterest (PINS) to Outperform from ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...
Tesla (TSLA, $845.00) stock has the potential to reach $950 per share, says Wedbush analyst Daniel Ives. But he still doesn’t think you should buy it. The 11 Best Growth Stocks to Buy for 2021 ...
Wedbush upgraded HomeStreet (HMST) to Outperform from Neutral with an unchanged price target of $12. The shares sold off heavily last week after it was announced that FirstSun Capital’s (FSUN ...
Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is here. Wedbush said Snowflake was in the "sweet spot" to benefit from AI product demand.